Cancer of the Prostate: Molecular Genetics
211
carcinoma in the Utah Mormon genealogy,
Cancer Surv.
1
, 48–69.
Carpten, J., Nupponen, N., Isaacs, S., Sood, R.,
Robbins, C., Xu, J., Faruque, M., Moses, T.,
Ewing, C.,
Gillanders, E.,
Hu, P.,
Bu-
jnovszky, P., Makalowska, I., Baffoe-Bonnie,
A.,Faith,D.,Smith,J.,Stephan,D.,Wiley,K.,
Brownstein, M., Gildea, D., Kelly, B., Jenk-
ins, R., Hostetter, G., Matikainen, M., Schleut-
ker, J.,
Klinger, K.,
Connors, T.,
Xiang, Y.,
Wang, Z., De Marzo, A., Papadopoulos, N.,
Kallioniemi, O.P., Burk, R., Meyers, D., Gron-
berg, H., Meltzer, P., Silverman, R., Bailey-
Wilson, J.,
Walsh, P.,
Isaacs, W.,
Trent, J.
(2002) Germline mutations in the ribonucle-
ase L gene in families showing linkage with
HPC1,
Nat. Genet.
30
(2), 181–184.
Carruba, G.,
Miceli, D.,
D’Amico, D.,
et al.
(1995) Sex steroids up-regulate E-cadherin
expression
in
hormone-responsive
LNCaP
human prostate cancer cells,
Biochem. Biophys.
Res. Commun.
212
, 624–631.
Carter, B.S., Beaty, T.H., Steinberg, G.D., et al.
(1992)
Mendelian
inheritance
of
familial
prostate cancer,
Proc. Natl. Acad. Sci. U.S.A.
89
, 3367–3371.
Carter, B.S., Bova, G.S., Beaty, T.H., et al. (1993)
Hereditary prostate cancer: epidemiologic and
clinical features,
J. Urol.
150
, 797–802.
Carter, B.S., Epstein, J.I., Isaacs, W.B. (1990) Ras
gene mutations in human prostate carcinoma,
Cancer Res.
50
, 6830–6832.
Castagnaro, M.,
Yandell, D.W.,
Dockhorn-
Dworniczak, B.,
et al.
(1993)
Androgen
receptor gene mutations and p53 gene analysis
in advanced prostate cancer,
Verh. Dtsch. Ges.
Pathol.
77
, 119–123.
Chan, J.M.,
Stampfer, M.J.,
Giovannucci, E.,
et al. (1998) Plasma insulinlike growth factor-I
and prostate cancer risk: a prospective study,
Science
279
, 563–566.
Chen, C., Bhalala, H.V., Vessella, R.L., Dong,
J.T. (2003) KLF5 is frequently deleted and
down-regulated but rarely mutated in prostate
cancer,
Prostate
55
(2), 81–88.
Chen, W.C., Obrink, B. (1991) Cell-cell contacts
mediated by E-cadherin (uvomorulin) restrict
invasive behavior of L-cells,
J. Cell Biol.
114
,
319–327.
Cheng, K.D., Loeb, L.A. (1993) Genomic insta-
bility and tumor progression: mechanistic
considerations,
Adv. Cancer Res.
60
, 121–156.
Cheng, L., Nagabhushan, M., Pretlow, T.P., et al.
(1996) Expression of E-cadherin in primary
and metastatic prostate cancer,
Am
.J
.Pa
tho
l
.
148
, 1375–1380.
Cher, M.L., Bova, G.S., Moore, D.H., et al. (1996)
Genetic alterations in untreated metastases
and androgen-independent prostate cancer de-
tected by comparative genomic hybridization
and allelotyping,
Cancer Res.
56
, 3091–3102.
Cher, M.L., MacGrogan, D., Bookstein, R., et al.
(1994) Comparative genomic hybridization,
allelic imbalance, and fluorescence in situ
hybridization on chromosome 8 in prostate
cancer,
Genes
Chromosomes
Cancer
11
,
153–162.
Ching, K.Z.,
Ramsey, E.,
Pettigrew, N.,
et al.
(1993) Expression of mRNA for epidermal
growth factor, transforming growth factor-
alpha and their receptor in human prostate
tissue and cell lines,
Mol. Cell. Biochem.
126
,
151–158.
Cress, A.E.,
Rabinovitz, I.,
Zhu, W.G.,
Na-
gle, R.B. (1995) The alpha-6-beta-1 and alpha-
6-beta-4 integrins in human prostate can-
cer progression,
Cancer Metastasis Rev.
14
,
219–228.
Crundwell, M.C.,
Morton, D.G.,
Arkell, D.G.,
Phillips, S.M. (1999) Genetic instability in
incidentally discovered and advanced prostate
cancer,
BJU Int.
84
, 123–127.
Cunningham, J.M., Shan, A., Wick, M.J., et al.
(1996) Allelic imbalance and microsatellite
instability in prostatic adenocarcinoma,
Cancer
Res.
56
, 4475–4482.
Dahiya, R., Deng, G., Chen, K.M., et al. (1996)
P53 tumor-suppressor gene mutations are
mainly localised on exon 7 in human primary
and metastatic prostate cancer,
B
r
.J
.Can
c
e
r
74
, 264–268.
Dahiya, R., Lee, C., McCarville, J., et al. (1997)
High
frequency
of
genetic
instability
of
microsatellites in prostatic adenocarcinoma,
Int. J. Cancer
72
, 762–767.
Davis, D.L., Russell, D.W. (1993) Unusual length
polymorphism in human steroid 5 alpha-
reductase type 2 gene (SRD5A2),
Hum. Mol.
Genet.
2
, 820.
DeLange, T. (1994) Activation of telomerase in a
human tumor,
Proc. Natl. Acad. Sci. U.S.A.
91
,
2882–2885.
Deocampo, N.D., Huang, H., Tindall, D.J. (2003)
The role of PTEN in the progression and
survival of prostate cancer,
Minerva Endocrinol.
28
(2), 145–153.
previous page 885 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online next page 887 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online Home Toggle text on/off